Genedrive PLC - Holding(s) in Company
Released
Released
Announcement PDF
RNS Number : 0460D
Genedrive PLC
16 June 2023
TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer in Microsoft Word format if possible)i
1a. Identity of the issuer or the underlying issuer of
Genedrive Plc
existing shares to which voting rights are attachedii:
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify)iii:
3. Details of person subject to the notification obligationiv
RiverFort Global Opportunities PCC Ltd
Name
City and country of registered office (if applicable)
4. Full name of shareholder(s) (if different from 3.)v
Jarvis Investment Management Ltd
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or
reachedvi:
6. Date on which issuer notified (DD/MM/YYYY):
14th June 2023
16th June 2023
7. Total positions of person(s) subject to the notification obligation
% of voting rights
attached to shares
(total of 8. A)
% of voting rights
through financial
instruments
(total of 8.B 1 + 8.B
2)
Total of both in %
(8.A + 8.B)
Total number of voting
99,049,946
Resulting situation
on the date on
which threshold
was crossed or
reached
<3%
<3%
Position of previous
notification (if
applicable)
6.56%
6.56%
rights of issuervii
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares
ISIN code (if possible)
Number of voting rightsix
% of voting rights
Indirect
Direct
(Art 9 of Directive
2004/109/EC) (DTR5.1)
(Art 10 of Directive
2004/109/EC)
(DTR5.2.1)
Direct
Indirect
(Art 9 of Directive
2004/109/EC) (DTR5.1)
Ordinary Shares
(GB00BH3X7Y70)
2,950,000
<3%
SUBTOTAL 8. A
2,950,000
<3%
(Art 10 of Directive
2004/109/EC) (DTR5.2.1)
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial
instrument
Expiration
datex
Exercise/
Conversion Periodxi
Number of voting rights
that may be acquired if
the instrument is
exercised/converted.
% of voting rights
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
Exercise/
Physical or
Type of
Expiration
Number of
Conversion
cash
financial
% of voting rights
voting rights
datex
instrument
Period xi
settlementxii
SUBTOTAL
8.B.2
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does
not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal
entityxiv (please add additional rows as necessary)
Namexv
% of voting rights if it
equals or is higher than
the notifiable threshold
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
% of voting rights
through financial
instruments if it equals
or is higher than the
notifiable threshold
Total of both if it equals or
is higher than the
notifiable threshold
11. Additional informationxvi
The Ordinary Shares are held by Jarvis Investment Management in CREST for the benefit of RiverFort Global
Opportunities PCC Ltd.
Place of completion
London, England
Date of completion
16 June 2023
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of
this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy
Policy.
END
HOLFLFFVREIRLIV
Share your feedback
Discover